Media coverage
1
Media coverage
Title Eli Lilly enters crowded ulcerative colitis market with delayed FDA approval for Omvoh Media name/outlet FiercePharma Country/Territory United States Date 27/10/23 Persons Bruce E. Sands
Eli Lilly enters crowded ulcerative colitis market with delayed FDA approval for Omvoh
Press/Media